2Grandi A M, Santillo R, Zanzi P, et al. Microalbuminurina in never-treated hypertensives: Lack of relationship to hyperinsulinemia and genetic predisposition to hypertension. Am J Hypertens, 2000, 13(4 Pt 1) .. 353--358.
3Tierney W M, Harris L E, Copley J B, et al. Effect of hypertension and type IT diabetes on renal function in an urban population. Am J Hypertens, 1990, 3:69--75.
4Messerli F H, Garavaglia G E, Schmieder R E, et al.Disparate cardiovascular finding in man and woman with essential hypertension. Ann Intern Med, 1987, 107:158--161.
5James M A, Fotherby M D, Potter J F. Microalbuminuria in elderly hypertensives: Reproducibility and relation to clinic and ambulatory blood pressure. J Hypertens, 1994, 12:309--313.
6Mancia G, Parati G. The role of ambulatory blood pressure monitoring in elderly hypertensive patients.Blood Press, 2000,2:12--16.
7Porush J G. Hypertension and chronic renal failure:The use of ACE inhibitors. Am J Kidney Dis, 1998,31 : 177-- 184.
8James MA, Fotherby MD, Potter JF. Microalbuminuria in elderly hypertensive: Reproducibility and relation to clinic and ambulatory blood pressure[J].J Hypertens,1994,12:309-313.
9Mackenzie HS, Troy JL, Rennke HG, et al. TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation[J].J Hypertens,1994,12:S11-15.
10Parving HH, Lehnert H, Brochnner J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes[J].N Engl Med,2001,345:870-878.
